U.S. Representatives: Don’t Dial Back Opioid Response Now
RX Drug Abuse & Heroin Summit.
In Wednesday’s morning plenary session in the Rx Drug Abuse & Heroin Summit, three U.S. representatives expressed cautious optimism about the nation’s drug overdose death rate dropping by 4.6% in 2018—the first decline recorded in decades—but added that neither that development nor the COVID-19 crisis is a reason to throttle back now.
“For the first time in literally 20 years, the number of Americans who lost their lives to opioid overdose declined. Think about that. That’s bending the curve in a productive way. But obviously, the fight is not over. We’ll have to continue in the years ahead to devote additional resources to research, law enforcement and, most importantly, finding ways to help folks who have become addicted—usually through no fault of their own, usually by following a legitimate prescription given to them by a medical professional."
Officials worry of potential spike in overdose deaths amid COVID-19 pandemic
ABC news
Health officials worry extended isolation could exacerbate the problem. Health officials acknowledged there could be a myriad of potential factors behind the increase of overdoses in some communities, with a primary concern being the obstacles that social distancing orders have created for public health services like addiction clinics and syringe exchange services.
For Drug Users, COVID-19 Poses Added Dangers
U.S. News
The National Institute on Drug Abuse director warns the coronavirus could increase the pressure to use, cause complicated health effects and curtail access to treatment for those struggling with addiction. As the novel coronavirus spreads and more states issue stay-at-home orders in the U.S., the head of the National Institute on Drug Abuse says social isolation and overburdened health systems could paint a dire picture for people struggling with addiction.
"Every one of us is affected by COVID – maybe we don't get infected, (but) we're all anxious because of the uncertainties" surrounding it, NIDA Director Dr. Nora Volkow says. "How we cope with that anxiety is very much dependent on multiple factors, including our circumstances, but one of the ways that people cope with it is by taking drugs."
Rx Drug Abuse & Heroin Summit 2020
The Rx Drug Abuse & Heroin Summit, a 2020 Virtual Experience, begins today through April 16. VCBH staff have been attending the Rx Summit since its inception in 2012. We brought back the inspiration and the momentum of the Rx Summit annually to inform our efforts to address the opioid crisis at home in Ventura County.
“The same power, the same drive that prompted you to be a part of the solution – to beat back the opioid epidemic, to save lives, and bring illegal drug dealers to justice – it’s that same victorious spirit that will carry this nation through the coronavirus pandemic. Together, we have witnessed a dramatic shift in the stigma behind drug abuse, and most importantly we have seen the number of overdose deaths finally decrease across the country – falling from more than 70,000 in 2017 to under 68,000 in 2018, according to the CDC. It’s a direct result of your comprehensive work. We have ambushed the opioid epidemic on every side – through improvements in law enforcement, treatment and education.” - Congressman Hal Rogers
COVID-19: Potential Implications for Individuals with Substance Use Disorders
We know very little right now about COVID-19 and even less about its intersection with substance use disorders. But we can make educated guesses based on past experience that people with compromised health due to smoking or vaping and people with opioid, methamphetamine, cannabis, and other substance use disorders could find themselves at increased risk of COVID-19 and its more serious complications—for multiple physiological and social/environmental reasons. The research community should thus be alert to associations between COVID-19 case severity/mortality and substance use, smoking or vaping history, and smoking- or vaping-related lung disease. We must also ensure that patients with substance use disorders are not discriminated against if a rise in COVID-19 cases places added burden on our healthcare system.
NIDA. (2020, April 6). COVID-19: Potential Implications for Individuals with Substance Use Disorders. Retrieved from https://www.drugabuse.gov/about-nida/noras-blog/2020/04/covid-19-potential-implications-individuals-substance-use-disorders on 2020, April 10